These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 11288641)

  • 1. [Clinical trial of Magnerot in the treatment of a threatened abortion after a previous delivery].
    Kavardzhikova S
    Akush Ginekol (Sofiia); 2000; 40(4):54-5. PubMed ID: 11288641
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tocolytic substituent treatment with Magnerot in threatened abortions and premature labor from the 16th to the 36th gestational week].
    Damianov L; Negentsov N; Ivanov S; Novachkov V; Tsachev K
    Akush Ginekol (Sofiia); 1995; 34(3):78-81. PubMed ID: 8743863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Our experience in using brikanil tokolytic therapy].
    Grigorov S; Despodova Ts; Serdev V
    Akush Ginekol (Sofiia); 1983; 22(4):273-7. PubMed ID: 6670698
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tocolytic treatment of pregnant women with threatened abortions and preterm labor in the second and third trimesters of pregnancy with magne B6 (a preliminary communication)].
    Marinov B; Damianov L; Tsache K; Atanasova B
    Akush Ginekol (Sofiia); 1999; 38(1):74-6. PubMed ID: 11965731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical results of treatment with orciprenaline of threatened abortion of premature labor. Use of Alupent in obstetrics].
    Conte D; Cisotto F
    Minerva Ginecol; 1972 Apr; 24(6):309-19. PubMed ID: 4671739
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hysterographic studies of uterine contractile activity during partusysten treatment of threatened late abortion and premature labor].
    Vinnyts'kyĭ OI
    Pediatr Akus Ginekol; 1979; (4):40-1. PubMed ID: 514659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined intensive pharmacotherapy in premature labor with habitual abortion and threatened abortion].
    Maksimov GP; Chernega MIa; Zaĭtsev LM
    Vrach Delo; 1988 Jul; (7):76-9. PubMed ID: 3188477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of threatened abortion and premature delivery with Duvadilan and Dilatol].
    Hengst P; Neumann H
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):850-4. PubMed ID: 4946946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Magnesium sulfate treatment of threatened late abortions and premature labor].
    Penev I; Pavlova F; Naumov I; Shtereva K; Vlasova D
    Akush Ginekol (Sofiia); 1981; 20(4):265-8. PubMed ID: 7304843
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities and limits of tocolytic treatment].
    Brütigam R; Lechner G
    Wien Med Wochenschr; 1977 May; 127(10):320-6. PubMed ID: 878495
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of threatened abortion and premature labor with isoxsuprine hydrochloride].
    Scillieri P; Grossi F
    Arch Ostet Ginecol; 1971; 76(4):129-37. PubMed ID: 5153115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of Intaserin for the therapy of premature labor and abortion].
    Izuchi S; Kuga S; Yamashita H
    Sanfujinka No Jissai; 1969 Feb; 18(2):181-4. PubMed ID: 5818866
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the administration of tocopherol on threatened abortion, premature labor and toxemia of late pregnancy.
    Akasu F; Tateno M
    J Jpn Obstet Gynecol Soc; 1966 Apr; 13(2):91-7. PubMed ID: 5973837
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of threatened abortion and premature labor with Duvadilan].
    Neumann H; Manteuffel U
    Zentralbl Gynakol; 1970 Aug; 92(34):1100-8. PubMed ID: 4102713
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion].
    Sola O; Colonna-Romano L
    Arch Ostet Ginecol; 1974; 79(5-6):326-35. PubMed ID: 4471560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy in threatened abortion and premature labor].
    Kikawa G
    Josanpu Zasshi; 1976 Dec; 30(12):750-2. PubMed ID: 1051650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of a natural progesterone associated with a synthetic progestogen and vitamin E in the treatment of threatened abortion and premature labor].
    Panariello S
    Arch Ostet Ginecol; 1970 Dec; 75(6):492-506. PubMed ID: 5526026
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of threatened preterm labor. A comparative study between 2 beta-mimetics].
    Lowenberg E; Escobedo F; García P; Ahued R; Jiménez L
    Ginecol Obstet Mex; 1988 May; 56():111-5. PubMed ID: 3154223
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of threatening abortion with diaphylline].
    Illei G; Horváth B
    Orv Hetil; 1977 May; 118(21):1239-40. PubMed ID: 325463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.